This paper is in the following e-collection/theme issue:

Early Results from COVID-19 Studies (300) JMIR Theme Issue: COVID-19 Special Issue (2453) Smoking Cessation (558) Outbreak and Pandemic Preparedness and Management (1730) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1518) Infectious Diseases (non-STD/STI) (1576) Telehealth and Telemonitoring (1681) Digital Health, Telehealth and e-Innovation in Clinical Settings (407) Clinical Communication, Electronic Consultation and Telehealth (596)

Published on in Vol 5, No 4 (2021): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25541, first published .
Transitioning to Remote Clinic Visits in a Smoking Cessation Trial During the COVID-19 Pandemic: Mixed Methods Evaluation

Transitioning to Remote Clinic Visits in a Smoking Cessation Trial During the COVID-19 Pandemic: Mixed Methods Evaluation

Transitioning to Remote Clinic Visits in a Smoking Cessation Trial During the COVID-19 Pandemic: Mixed Methods Evaluation

Authors of this article:

Martin Christopher Mahoney1 Author Orcid Image ;   Eunhee Park2 Author Orcid Image ;   Nicolas J Schlienz3 Author Orcid Image ;   CeCe Duerr3 Author Orcid Image ;   Larry W Hawk3 Author Orcid Image
Article Authors Cited by (8) Tweetations (2) Metrics

Journals

  1. de Vargas D, Pereira C, Volpato R, Lima A, da Silva Ferreira R, de Oliveira S, Aguilar T. Strategies Adopted by Addiction Facilities during the Coronavirus Pandemic to Support Treatment for Individuals in Recovery or Struggling with a Substance Use Disorder: A Scoping Review. International Journal of Environmental Research and Public Health 2021;18(22):12094 View
  2. Davies N, Callister M, Copeland H, Griffiths S, Holtam L, Lambert P, Mathur J, Thorley R, Murray R. Opportunistic Non-Governmental Organisation Delivery of a Virtual Stop Smoking Service in England during the COVID-19 Lockdown. International Journal of Environmental Research and Public Health 2022;19(13):7722 View
  3. Parkin G, Thomas E. Provider Perspectives on the Current Use of Lithium Medications and Lithium Monitoring Practices for Psychiatric Conditions. Neuropsychiatric Disease and Treatment 2022;Volume 18:2083 View
  4. Naz-McLean S, Kim A, Zimmer A, Laibinis H, Lapan J, Tyman P, Hung J, Kelly C, Nagireddy H, Narayanan-Pandit S, McCarthy M, Ratnaparkhi S, Rutherford H, Patel R, Dryden-Peterson S, Hung D, Woolley A, Cosimi L, Thet Wai K. Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study. PLOS ONE 2022;17(6):e0269127 View
  5. Novalen M, Chenoweth M, Zhao B, Hawk L, Tyndale R. Stability of Varenicline Concentration in Saliva Over 21 Days at Three Storage Temperatures. Nicotine & Tobacco Research 2022;24(2):270 View
  6. Weissler E, Stebbins A, Wruck L, Muñoz D, Gupta K, Girotra S, Whittle J, Benziger C, Polonsky T, Bradley S, Hammill B, Merritt J, Zemon D, Hernandez A, Jones W. Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study. Vascular Medicine 2023;28(2):122 View
  7. Olugemo K, Bugarski-Kirola D, Dawson G, DiCesare F, Stevanović D, Samardzic J, Chatzittofis A, Moore R, Verster J, Bhering L, Vieta E. Conducting CNS trials during a public health emergency – Lessons learned from the COVID-19 pandemic: A joint ISCTM/ECNP working group consensus paper. Neuroscience Applied 2023;2:101129 View
  8. Woodrow N, Gillespie D, Kitchin L, O’Brien M, Chapman S, Chng N, Passey A, Aquino M, Clarke Z, Goyder E. Reintroducing face-to-face support alongside remote support to form a hybrid stop smoking service in England: a formative mixed methods evaluation. BMC Public Health 2024;24(1) View